Tech Company Financing Transactions
VitaPath Genetics Funding Round
Private investors invested in a $4.7 million Series C funding round for VitaPath Genetics. This venture round was announced on 5/11/2012.
Transaction Overview
Company Name
Announced On
5/11/2012
Transaction Type
Venture Equity
Amount
$4,710,428
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
348 Hatch Drive
Foster City, CA 94404
USA
Foster City, CA 94404
USA
Phone
Website
Email Address
Overview
The company is a developer of molecular diagnostics designed to help patients and their doctors correct genetic mutations that can result in diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce Cohen
Chief Scientific Officer
Dennis Gilbert
Browse more venture capital transactions:
Prev: 5/11/2012: M9 Defense venture capital transaction
Next: 5/11/2012: Agilence venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs